Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis
Helicobacter · 2023-12 · 28 (6)
DOI: 10.1111/hel.13013 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Helicobacter, online erschienen am 21.08.2023. Verfasst von Fangyuan Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Traditional and Western Medicine in Oncology, The First Affiliated Hospital of Medical University of Anhui, Hefei, China. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Stomach Neoplasms, Precancerous Conditions. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Anhui Provincial Natural Science Foundation of China, National Natural Science Foundation of China, Natural Science Foundation of the Anhui Higher Education Institutions of China.
Abstract (Originalsprache)
Background
The question of whether eradication of Helicobacter pylori (Hp) can reverse gastric precancerous lesions, including intestinal metaplasia, remains uncertain, leading to ongoing debate. Therefore, a meta‐analysis was performed to evaluate the effect of Hp eradication on gastric precancerous lesions. Materials and Methods PubMed, Embase, Cochrane Library, Web of Science, Scopus database, and ClinicalTrials.gov were systematically searched from inception to April 2023 for studies that explored the impact of Hp eradication on gastric precancerous lesions. Risk ratios (RRs) and their 95% confidence intervals (95% CIs) were selected as the effect size. We used the random‐effects model to assess pooled data. We also performed quality assessments, subgroup analyses, and sensitivity analyses.
Results
Fifteen studies were included. Compared with placebo, Hp eradication could significantly prevent the progression of gastric precancerous lesions (RR = 0.87, 95% CI: 0.81–0.94, p < 0.01) and reverse them (RR = 1.32, 95% CI: 1.17–1.50, p < 0.01). Then, specific precancerous lesions were further explored. The progression of intestinal metaplasia was significantly prevented by Hp eradication compared to placebo or no treatment (RR = 0.80, 95% CI: 0.69–0.94, p < 0.01). Moreover, compared with placebo or no treatment, Hp eradication also improved chronic atrophic gastritis (RR = 1.84, 95% CI: 1.30–2.61, p < 0.01) and intestinal metaplasia (RR = 1.41, 95% CI: 1.15–1.73, p < 0.01). However, in terms of preventing dysplasia progression (RR = 0.86, 95% CI: 0.37–2.00) and improving dysplasia (RR = 0.89, 95% CI: 0.47–1.70), Hp eradication had no advantage compared to placebo or no treatment.
Conclusions
Hp eradication therapy could prevent the progression of gastric precancerous lesions and reverse them. Notably, intestinal metaplasia can be reversed, but this may only be appropriate for patients with epigenetic alterations and milder lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Integrated Traditional and Western Medicine in Oncology, The First Affiliated Hospital of Medical University of Anhui, Hefei, China.
ORCID-Profile: Fangyuan Zhu, Yaodong Zhu
Förderung
- Anhui Provincial Natural Science Foundation of China
- National Natural Science Foundation of China
- Natural Science Foundation of the Anhui Higher Education Institutions of China
Zitieren
APA
Zhu, F., Zhang, X., Li, P., & Zhu, Y. (2023). Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis. Helicobacter, 28(6). https://doi.org/10.1111/hel.13013
Vancouver
Zhu F, Zhang X, Li P, Zhu Y. Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis. Helicobacter. 2023;28(6). doi:10.1111/hel.13013
BibTeX
@article{Zhu2023,
author = {Zhu, Fangyuan and Zhang, Xiaoze and Li, Ping and Zhu, Yaodong},
title = {Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis},
journal = {Helicobacter},
year = {2023},
volume = {28},
number = {6},
doi = {10.1111/hel.13013}
}
EUVIMED